Summary We have examined the proliferative response (DNA synthesis) of primary thyroid epithelial cultures to serum and a defined serum-substitute. These cultures were derived from normal human thyroid and from thyroid adenomas and carcinomas. All normal cultures showed a dose-dependent response, with a maximum 3H-thymidine labelling index of around 50%. Three out of the four adenomas demonstrated a much reduced or delayed response under the same conditions. In two carcinomas, labelling was never more than 5% and in one case was undetectable. This inverse relationship between the degree of in vivo malignancy and proliferative response in vitro has important implications for the interpretation of tissue culture models of epithelial neoplasia and also offers the potential for isolating novel growth factors specific for thyroid cancer cells.
The thyroid provides a convenient experimental model for studying the molecular basis of human epithelial malignancy. Like colon, it provides a well-defined spectrum of benign and malignant tumours, but offers the important advantage of a much simpler tissue organisation. Indeed, if the tiny complement of C cells is ignored, the normal thyroid effectively contains a homogeneous population of epithelial cells in a single differentiation and cell kinetic state (Wynford-Thomas & . In addition, the structural organisation into follicles (which is fortunately preserved in many differentiated tumours) greatly facilitates preparation of pure primary cultures of these epithelial cells free of stromal contamination (Williams et al., 1987; Williams & WynfordThomas, 1990 ) from both normal and neoplastic tissue.
Clearly a major application of this experimental system is the direct comparison of proliferative and biochemical responses to growth factors of normal, benign and malignant thyroid epithelium. We have already successfully employed this approach to demonstrate an important difference in the requirement for insulin-like growth factor 1 (IGF-1) between normal and benign thyroid tumour cells (Williams et al., 1988) and obtained evidence pointing to autocrine production in the latter .
In attempting to extend this work to malignant epithelia we were surprised to find that although viable monolayers were readily obtainable from thyroid cancers, they showed a striking lack of proliferative activity (DNA synthesis) compared to both normal and adenoma-derived cultures. We have therefore carried out a systematic comparison of the responsiveness of normal, benign and malignant thyroid epithelia to serum growth factors.
Materials and methods

Tissue
Tumour tissue was obtained fresh from surgical thyroidectomies performed for removal of a 'solitary thyroid nodule', samples (adenoma or carcinoma) being dissected out from the centre of the nodule. Normal tissue, in three cases, was taken from the periphery of the lobectomy specimen, distant from the tumour, in a macroscopically normal region. In addition fresh normal tissue was also obtained from a 30 year old transplant donor patient with no thyroid disease and normal histology (graph c, Figure 1 ; case III, Figure 2 ).
Histological confirmation of the normal or neoplastic status of each sample was carried out retrospectively.
Four adenomas were studied (Table I ). All were solitary, encapsulated tumours and were classified as macro-or microfollicular on the basis of follicle size relative to normal, as in previous studies (Lemoine et al., 1989) . None showed evidence of capsular or vascular invasion on examination of multiple tissue blocks.
Three carcinomas were studied (Table I) . Two were minimally invasive follicular carcinomas of good-to-moderate differentiation with the histological appearance of an adenoma except for the presence of definite capsular or angio-invasion, this being the essential diagnostic criterion of malignancy. The third was a moderately-differentiated widely-invasive follicular carcinoma.
Primary culture Both normal and tumour derived cultures were prepared by collagenase/dispase digestion together with mechanical disaggregation as described previously (Williams et al., 1988; Williams & Wynford-Thomas, 1990 (Figure 2b ). The maximum 48 h LI was only 5.5 ± 0.7% (mean ± s.e.) in one case (SR, Figure  le ) and 11.6 ± 2.9% in a second (JB, Figure If) There is of course a precedent for this in other epithelial tissues. It has been known for many years that breast carcinoma cells are more difficult to culture than the corresponding normal. Quantitative comparisons have confirmed this lower response to serum and/or purified growth factors (Kirkland et al., 1979) and indicate, as in thyroid, an inverse correlation between in vivo malignancy and in vitro growth (Buehring & Williams, 1976 A major advance towards this goal would be the ability to reversibly switch on cancer cell growth in vitro. Recent studies of the tumour suppressor gene p53 (Bartek et al., 1990) demonstrate that in that minority of cases where lines have been obtained from breast cancers, they have a mutation of this gene which appears to abolish its tumour suppressor activity and additionally inhibits the action of normal p53. Furthermore, in the one known case of differentiated thyroid cancer in which a line was obtained (from more than 100 cases; Goretzki et al., 1989) -FTC 133 -we have recently shown that this too, has a p53 mutation (Wyllie et al. -in publication; Wright et al. -submitted). This therefore strongly suggests that whatever the basis for the lack of growth response in cancer cells, it may be directly overcome by the expression of a mutant p53. The recent availability of a temperature-sensitive mutant of p53 (Michalovitz et al., 1990) now raises the exciting possibility that introduction of this gene into primary thyroid carcinoma cells would generate lines with inducible growth which would be the ideal substrate for isolating the missing stimuli for in vitro cancer growth.
